Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vancomycin for Prophylaxis of PEG-Related Wound Infection in MRSA-Positive Patients: a Double-Blind, Randomized, Placebo-Controlled Study

NCT00150852 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.

NCT NCT00150852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00150852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vancomycin for Prophylaxis of PEG-Related Wound Infection in MRSA-Positive Patients: a Double-Blind, Randomized, Placebo-Controlled Study
Lead sponsor
University Hospital, Geneva
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2004
Completion date
Not reported
Enrollment
96
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

wound infection